Menomedin (Trifolium pratense) capsules №30

Description

Menomedin composition
Main active ingredients: extracts of red clover (Trifolium pratense, 150 mg), sage (Salvia officinalis, 100 mg), St. John’s wort (Hypericum perforatum, 60 mg), angelica (Angelica sinensis, 45 mg) and black cohosh (cimifuga, Black Cohosh / Cimicifuga racemosa, 25 mg).

Release form
The drug is sold in gelatin capsules weighing 400 mg.

Pharmacological properties
This phytopreparation Menomedin is recommended to normalize the functioning of the functional state of the organs and systems of a woman during menopause.
The active substances that are part of the extracts of the main active ingredients – red clover, sage, St. John’s wort, angelica and black cohosh – have a positive effect on the female reproductive system, normalizing hormonal levels during menopause. The use of this drug, which contains estrogen-like substances, can reduce the symptoms of the onset of menopause, reduce hot flashes, sweating and dryness of the genitals, prevent bone loss and inhibit its resorption, which helps prevent the development of osteoporosis.
Sleep improves during menopause, after oophorectomy or hysterectomy, and the painfulness of menstruation decreases during premenopause. It has a positive effect on cognitive functions, memory and attention, produces an antioxidant effect, normalizes the lipid profile, which prevents the progression of cardiovascular and neurological pathology. Reduces the manifestation of nervousness, depression, anxiety.

Indications
The considered balanced natural complex Menomedin is an additional source of biologically active substances of plant origin for the normalization of the functional state of the organs and systems of a woman during menopause.
In particular, this drug:

• normalizes the functioning of the nervous and reproductive system, mammary glands, skin, bones during menopause and premenopause;
• helps to reduce neurovegetative manifestations – hot flashes, night sweats, dry genitals;
• improves psycho-emotional state with nervousness, anxiety, depression, insomnia;
• contributes to the adaptation of the female body to age-related changes during the period of hormonal changes, prevents the development of osteoporosis, cardiovascular disorders during the climacteric and postmenopausal periods.

Contraindications
The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or one of the auxiliary components.

Application during pregnancy and lactation
During pregnancy, the appointment of this drug is possible only after consultation with your doctor.
If there is a need to take the drug during lactation, then it should be suspended for the period of treatment.

Method of administration and dosage
Menomedin is taken orally with a sufficient amount of liquid.
Adults take 1-2 capsules a day, regardless of food intake.
The duration of the course of treatment is from 3 to 6 months. If necessary, the course of treatment can be repeated.
Correction of the recommended dosage, the duration of the course of treatment and the frequency of therapeutic courses are determined by the attending physician.

Overdose
Overdose has not yet been recorded and is unlikely.
In case of accidental overdose, symptomatic treatment should be performed.

Side effects
The drug is usually well tolerated.
When treating with this drug, side effects can occur only when hypersensitivity to individual components of the drug occurs. In this case, you may experience:

• disorders of the gastrointestinal tract, nausea;
• allergic urticaria, itching.

If you experience any unspecified side effects, you should consult your doctor.

Storage conditions and periods
Shelf life – no more than 2 years from the date of issue indicated on the packaging by the manufacturer.
The storage temperature should not exceed 25 ° C or be below 4 ° C.